SCHEMBL21760038

SCHEMBL21760038

CCc1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2O

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.44
▸ DDB1 Q16531 9/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25899542 0.91 CRBN (0.41) CRBNDDB1
SCHEMBL22733426 0.89 CRBN (0.44) CRBNDDB1
SCHEMBL25951897 0.88 CRBN (0.40) CRBNDDB1
SCHEMBL25900179 0.85 CRBN (0.48) CRBNDDB1
SCHEMBL24294674 0.85 CRBN (0.45) CRBNDDB1
SCHEMBL20323937 0.85 CRBN (0.45) CRBNDDB1
SCHEMBL25771919 0.83 CRBN (0.46) CRBNDDB1
SCHEMBL29307105 0.83 CRBN (0.43) CRBNDDB1
SCHEMBL22512216 0.82 CRBN (0.57) CRBNDDB1
SCHEMBL19559158 0.82 CRBN (0.50) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3594211-B1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF CELGENE CORP (US) 2023-10-25 — — EP disclosed
WO-2020038415-A1 TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE CULLGEN (SHANGHAI), INC. (CN) 2020-02-27 — — WO disclosed
Send feedback